# Exelon Patch and Combination With Memantine Comparative Trial

> **NCT01025466** · PHASE4 · COMPLETED · sponsor: **Inha University Hospital** · enrollment: 206 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Rivastigmine transdermal patch (Exelon patch), memantine
- **DRUG:** Rivastigmine transdermal patch

## Key facts

- **NCT ID:** NCT01025466
- **Lead sponsor:** Inha University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-11
- **Final completion:** 2010-04
- **Target enrollment:** 206 (ACTUAL)
- **Last updated:** 2010-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01025466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01025466, "Exelon Patch and Combination With Memantine Comparative Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01025466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*